AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,162,000 | +289.8% | 336,931 | +82.9% | 0.01% | +400.0% |
| Q3 2019 | $5,173,000 | -16.9% | 184,173 | +12.0% | 0.00% | -50.0% |
| Q2 2019 | $6,225,000 | +1780.7% | 164,429 | +1838.1% | 0.00% | – |
| Q1 2019 | $331,000 | -96.6% | 8,484 | -98.2% | 0.00% | -100.0% |
| Q4 2018 | $9,876,000 | +93.7% | 463,228 | +259.6% | 0.00% | +200.0% |
| Q3 2018 | $5,099,000 | -36.3% | 128,805 | -38.5% | 0.00% | -50.0% |
| Q2 2018 | $8,000,000 | +5.0% | 209,378 | -17.5% | 0.00% | 0.0% |
| Q1 2018 | $7,622,000 | +280.1% | 253,659 | +295.2% | 0.00% | +100.0% |
| Q4 2017 | $2,005,000 | -52.5% | 64,179 | -57.4% | 0.00% | 0.0% |
| Q3 2017 | $4,219,000 | +1137.2% | 150,650 | +745.4% | 0.00% | – |
| Q2 2017 | $341,000 | +9.3% | 17,820 | -2.3% | 0.00% | – |
| Q1 2017 | $312,000 | -48.9% | 18,248 | -45.4% | 0.00% | – |
| Q4 2016 | $610,000 | – | 33,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |